Alimera Sciences To Present At Jefferies Healthcare Conference
ATLANTA, May 27, 2014
ATLANTA, May 27, 2014 /PRNewswire/ --Alimera Sciences, Inc. (Nasdaq: ALIM)
("Alimera"), a biopharmaceutical company that specializes in the research,
development and commercialization of prescription ophthalmic pharmaceuticals,
today announced that Dan Myers, president and chief executive officer, will
present at the Jefferies 2014 Healthcare Conference on Thursday, June 5, 2014
at 1:30 P.M. ET in New York, NY.
The presentation will be webcast live and will be available for access on the
Investor Relations section of the corporate website at
http://www.alimerasciences.com. For those who are not available to listen to
the live broadcast, the webcast will be archived for 90 days.
About Alimera Sciences, Inc.
Alimera Sciences, Inc., headquartered in Alpharetta, Georgia, is a
biopharmaceutical company that specializes in the research, development and
commercialization of prescription ophthalmic pharmaceuticals. Alimera's
European operations are conducted from London by its wholly-owned subsidiary,
Alimera Sciences Limited.
for Alimera Sciences
SOURCE Alimera Sciences, Inc.
Press spacebar to pause and continue. Press esc to stop.